Panbela Therapeutics, Inc.

Pharmaceutical Preparations·WACONIA, MN

CEO

Simpson Jennifer K.

CFO

Horvath Susan

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
10-Q	Q1 2024	3/31/24	5/15/24	→
10-K	FY 2023	12/31/23	3/26/24	→
10-Q	Q3 2023	9/30/23	11/9/23	→
10-Q	Q2 2023	6/30/23	8/10/23	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
11/14/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
5/15/24	Q2 FY2024	→
3/26/24	Q1 FY2024	→
11/9/23	Q4 FY2023	→
8/10/23	Q3 FY2023	→
↓

News (8-K)

60 shown

Filed	Type	Description
2/18/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/4/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/22/25	Ctrl Change	Triggering Events Affecting Repayment of Debt	→
11/18/24	Ctrl Change	Entry into a Material Definitive Agreement	→
10/28/24	Agreement	Entry into a Material Definitive Agreement	→
9/27/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/10/25	S-8	S-8	→
11/18/24	424B3	424B3	→
11/18/24	424B3	424B3	→
11/18/24	424B3	424B3	→
11/18/24	424B3	424B3	→
11/18/24	424B3	424B3	→
↓

Filing History(584 filings)

TypeDateAccessionPeriodSize

SEC STAFF ACTION

Sep 29, 2025

9999999997-25-003686

—

4.1 KB

SCHEDULE 13D/A

Apr 24, 2025

0000950170-25-058254

—

12.1 KB

8-K

Feb 18, 2025

0001437749-25-004225FORM 8-K

Feb 12, 2025

137.4 KB

8-K

Feb 4, 2025

0001437749-25-002718FORM 8-K

Jan 29, 2025

157.0 KB

8-K

Jan 22, 2025

0001437749-25-001557FORM 8-K

Jan 20, 2025

142.7 KB

S-8

Jan 10, 2025

0001437749-25-000865FORM S-8

—

74.6 KB

Nov 19, 2024

0000950170-24-1289244

Nov 15, 2024

8.8 KB

424B3

Nov 18, 2024

0001437749-24-035643FORM 424B3

—

42.1 KB

424B3

Nov 18, 2024

0001437749-24-035641FORM 424B3

—

42.3 KB

424B3

Nov 18, 2024

0001437749-24-035640FORM 424B3

—

42.2 KB

424B3

Nov 18, 2024

0001437749-24-035639FORM 424B3

—

43.4 KB

424B3

Nov 18, 2024

0001437749-24-035636FORM 424B3

—

41.9 KB

424B3

Nov 18, 2024

0001437749-24-035635FORM 424B3

—

42.8 KB

424B3

Nov 18, 2024

0001437749-24-035634FORM 424B3

—

41.9 KB

8-K

Nov 18, 2024

0001437749-24-035616FORM 8-K

Nov 15, 2024

320.2 KB

424B3

Nov 15, 2024

0001437749-24-035416FORM 424B3

—

765.2 KB

424B3

Nov 15, 2024

0001437749-24-035415FORM 424B3

—

765.4 KB

424B3

Nov 15, 2024

0001437749-24-035413FORM 424B3

—

765.6 KB

424B3

Nov 15, 2024

0001437749-24-035414FORM 424B3

—

765.3 KB

424B3

Nov 15, 2024

0001437749-24-035410FORM 424B3

—

765.9 KB

424B3

Nov 15, 2024

0001437749-24-035412FORM 424B3

—

765.0 KB

424B3

Nov 15, 2024

0001437749-24-035411FORM 424B3

—

765.4 KB

10-Q

Nov 14, 2024

0001437749-24-035315FORM 10-Q

Sep 30, 2024

3.9 MB

8-K

Nov 14, 2024

0001437749-24-035305FORM 8-K

Nov 14, 2024

402.0 KB

SC 13D

Oct 29, 2024

0001193125-24-246727SC 13D

—

66.3 KB

25 filings shown

Filed	Form	Description
5/6/24	DEFR14A	FORM DEFR14A	→
4/25/24	DEFA14A	FORM DEFA14A	→
4/4/24	DEF 14A	DEF 14A	→
3/25/24	PRE 14A	FORM PRE 14A	→
12/21/23	DEFA14A	FORM DEFA14A	→
12/1/23	DEFA14A	FORM DEFA14A	→
↓

Panbela Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(584 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/19/24	4	4	→
10/29/24	SC 13D	SC 13D	→
10/29/24	3	3	→
10/3/24	4	4	→
10/3/24	4	4	→
2/13/24	SC 13G/A	SC 13G/A	→
↓

Filed	Form	Description
9/29/25	SEC STAFF ACTION	SEC STAFF ACTION	→
4/24/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
4/26/24	PRER14A	FORM PRER14A	→
4/25/24	25-NSE	25-NSE	→
4/15/24	EFFECT	EFFECT	→
4/2/24	EFFECT	EFFECT	→
↓